Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBeijing Tongren Hospital

About this trial

Allergic rhinitis (AR) is a non-infectious chronic inflammatory disease of the nasal mucosa mainly mediated by immunoglobulin E after exposure to allergens in atopic individuals. The typical symptoms of AR are paroxysmal sneezing, watery rhinorrhea, itching, and nasal congestion, which may be accompanied by ocular symptoms, including eye itching, tearing, redness, and burning sensation, which are more common in patients with hay fever allergies. Bronchial asthma is associated with bronchial asthma in 40% of patients with AR, suggesting a comorbid feature of allergic disease.

Eligibility criteria

Qualifiers

Voluntarily sign the informed consent form.

Disqualifiers

Have any condition that are not suitable for participating in this study.

Trial design

Treatments tested in this trial

  • Interleukin-4 receptor responders
  • Placebo

Treatment groups

120 Participants
are divided into 2 treatment groups

Sponsors and collaborators